兄弟科技(002562) - 2018 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2018 was ¥418,535,032.58, representing a 46.41% increase compared to ¥285,864,834.86 in the same period last year[8] - The net profit attributable to shareholders for Q1 2018 was ¥72,403,731.75, up 10.48% from ¥65,537,540.18 in the previous year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥71,298,551.27, an 18.11% increase from ¥60,368,546.44 year-on-year[8] - The basic earnings per share for Q1 2018 was ¥0.13, an increase of 8.33% compared to ¥0.12 in the same period last year[8] - The diluted earnings per share for Q1 2018 was also ¥0.13, reflecting the same 8.33% increase from the previous year[8] - The company expects net profit attributable to shareholders for the first half of 2018 to range between ¥7,723.43 million and ¥12,357.48 million, representing a decrease of 20% to 50% compared to ¥15,446.85 million in the same period of 2017[21] Cash Flow and Assets - The net cash flow from operating activities reached ¥117,960,913.55, a significant improvement of 317.55% compared to a negative cash flow of ¥54,223,089.53 in the same period last year[8] - The total assets at the end of the reporting period were ¥3,607,273,778.25, reflecting a 4.11% increase from ¥3,465,002,177.94 at the end of the previous year[8] - The net assets attributable to shareholders at the end of the reporting period were ¥2,357,558,830.52, up 3.15% from ¥2,285,509,056.27 at the end of the previous year[8] - The company's cash flow from operating activities improved significantly, amounting to ¥117,960,913.55, a 317.55% increase compared to a negative cash flow of ¥54,223,089.53 in the previous year[16] Operating Costs and Revenue Drivers - Operating costs rose to ¥241,566,943.65, reflecting a 59.02% increase from ¥151,914,148.10, attributed to the same factors driving revenue growth[16] - The company's revenue for the reporting period reached ¥418,535,032.58, an increase of 46.41% compared to ¥285,864,834.86 in the same period last year, primarily due to increased variety and sales of vitamin products[16] Investments and Financial Assets - The financial assets measured at fair value increased to ¥80,000,000.00, a 60% rise from ¥50,000,000.00, mainly due to increased purchases of principal-protected floating income financial products[16] - The company’s investment income decreased by 46.83% to ¥2,360,657.55 from ¥4,439,503.72, primarily due to reduced amounts invested in financial products[16] Other Financial Metrics - The weighted average return on equity was 3.35%, a slight decrease of 0.30% from 3.65% in the previous year[8] - The company reported non-recurring gains of ¥1,105,180.48 for the period, primarily from government subsidies and fair value changes of financial assets[9] - The company reported a significant increase in prepayments, which rose by 113.95% to ¥17,073,745.31 from ¥7,980,102.08, indicating increased customer advance payments[16] - The company’s construction in progress increased by 73.68% to ¥208,680,442.61 from ¥120,152,274.11, driven by the expansion of the Brother Pharmaceutical Phase II project[16] - The company’s financial expenses surged to ¥24,529,513.93, a dramatic increase of 5,826.27% from ¥413,911.57, mainly due to interest accruals on convertible bonds and increased exchange losses[16] - The company’s accounts receivable decreased by 59.68% to ¥28,570,091.50 from ¥70,857,979.58, attributed to an increase in the amount and proportion of accepted payments during the period[16]